Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636282-26-000050
Filing Date
2026-05-05
Accepted
2026-05-05 08:00:44
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syre-20260331.htm   iXBRL 10-Q 1380356
2 EX-31.1 spyre-20260331xex311.htm EX-31.1 9599
3 EX-31.2 spyre-20260331xex312.htm EX-31.2 9608
4 EX-32.1 spyre-20260331xex321.htm EX-32.1 7287
10 GRAPHIC syre-20260331_g1.jpg GRAPHIC 244844
11 GRAPHIC syre-20260331_g2.jpg GRAPHIC 354007
12 GRAPHIC syre-20260331_g3.jpg GRAPHIC 366014
13 GRAPHIC syre-20260331_g4.jpg GRAPHIC 319411
14 GRAPHIC syre-20260331_g5.jpg GRAPHIC 156028
15 GRAPHIC syre-20260331_g6.jpg GRAPHIC 200107
  Complete submission text file 0001636282-26-000050.txt   10639142

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syre-20260331.xsd EX-101.SCH 47378
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT syre-20260331_cal.xml EX-101.CAL 55446
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT syre-20260331_def.xml EX-101.DEF 326809
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syre-20260331_lab.xml EX-101.LAB 589079
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syre-20260331_pre.xml EX-101.PRE 451597
78 EXTRACTED XBRL INSTANCE DOCUMENT syre-20260331_htm.xml XML 881273
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 26940510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)